We are partnering with HSIPT to conduct clinical trials on infectious diseases and R&D for novel cancer cell treatments.
Firstly, we possess nosodes/frequencies for 141 infectious diseases, most of which have already been successfully tested in Europe and North America; we are now initiating clinical trials for these in the Asian market.
Secondly, we are testing targeted cancer cell frequencies, focusing initially on skin and breast cancer patients, with plans to expand to other cancer types.
